To facilitate this, we retrieved tumor-level HER2 immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) data from a comprehensive 2018 study of the genomic landscape of endocrine resistance by Razavi et al. The gene discussed is ERBB2; the disease is neoplasm.